This includes features such as tumor mutational load (9, 10, 13, 23), clonal neoantigen load (24), HLA genotype (25, 26), immune infiltration into the tumor microenvironment (27), and expression of immune checkpoint molecules such as PD-1 and PD-L1 (28–30). Here, PDCD1 is linked to neoplasm.